People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| eyeBrain Medical, Inc. | — | Biotechnology | Series C | $126.3M | $1.2B | 2022 |
Aric Plumley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aric Plumley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Link | 1 | 11 |
| Eric Bednarski | 1 | 7 |
| Steve Kirby | 1 | 6 |
| J. Andy Corley | 1 | 5 |
| Steve T Kirby | 1 | 3 |
| Tom Frinzi | 1 | 3 |
| Akhilesh Pathipati | 1 | 2 |
| Pierre Bertrand | 1 | 2 |
| William T. Link | 1 | 2 |
| Tom Finzi | 1 | 1 |
| Das Narayandas | 1 | 1 |
| Danny Perales | 1 | 1 |
| Daniel Perales | 1 | 1 |
| Dean Butler | 1 | 1 |
| Davis Corley | 1 | 1 |
| Jeffrey Andy Krall | 1 | 1 |
| John T. Tullis | 1 | 1 |
| Davis Andy Corley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.